ATE202079T1 - Krampflösende, enantiomere aminosäure-derivate - Google Patents

Krampflösende, enantiomere aminosäure-derivate

Info

Publication number
ATE202079T1
ATE202079T1 AT97916897T AT97916897T ATE202079T1 AT E202079 T1 ATE202079 T1 AT E202079T1 AT 97916897 T AT97916897 T AT 97916897T AT 97916897 T AT97916897 T AT 97916897T AT E202079 T1 ATE202079 T1 AT E202079T1
Authority
AT
Austria
Prior art keywords
antispasmodic
amino acid
acid derivatives
enantiomeric amino
animal
Prior art date
Application number
AT97916897T
Other languages
English (en)
Inventor
Harold Kohn
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21760388&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE202079(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of ATE202079T1 publication Critical patent/ATE202079T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97916897T 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate ATE202079T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1352296P 1996-03-15 1996-03-15
PCT/US1997/004579 WO1997033861A1 (en) 1996-03-15 1997-03-17 Anticonvulsant enantiomeric amino acid derivatives

Publications (1)

Publication Number Publication Date
ATE202079T1 true ATE202079T1 (de) 2001-06-15

Family

ID=21760388

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00109377T ATE268169T1 (de) 1996-03-15 1997-03-17 Antikonvulsive enantiomerische aminosäurederivate
AT97916897T ATE202079T1 (de) 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00109377T ATE268169T1 (de) 1996-03-15 1997-03-17 Antikonvulsive enantiomerische aminosäurederivate

Country Status (12)

Country Link
EP (2) EP1038522B1 (de)
JP (1) JP3145414B2 (de)
AT (2) ATE268169T1 (de)
AU (1) AU718577B2 (de)
CA (1) CA2248317C (de)
DE (3) DE122009000010I2 (de)
DK (2) DK0888289T3 (de)
ES (2) ES2218024T3 (de)
FR (1) FR09C0006I2 (de)
NL (1) NL300376I1 (de)
PT (2) PT888289E (de)
WO (1) WO1997033861A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1642889A1 (de) 2004-10-02 2006-04-05 Schwarz Pharma Ag Verbessertes Syntheseschema für Lacosamid
EP1873527A1 (de) 2006-06-30 2008-01-02 Schwarz Pharma Ag Verfahren zur Identifizierung von CRMP-Modulatoren
US8093426B2 (en) 2007-12-04 2012-01-10 Ranbaxy Laboratories Limited Intermediate compounds and their use in preparation of lacosamide
DE102008059155A1 (de) 2008-11-27 2010-06-02 Ratiopharm Gmbh Trockenverarbeitung und neue Formen von Lacosamid
WO2011015617A1 (en) 2009-08-06 2011-02-10 Medichem, S.A. Solid forms of an n-(phenylmethyl)propanamide derivative and processes of preparation
US8853439B2 (en) * 2009-09-25 2014-10-07 Cadila Healthcare Limited Processes for the preparation of lacosamide and intermediates thereof
IT1398044B1 (it) * 2010-01-29 2013-02-07 Archimica Srl Processo per la preparazione della lacosamide
EP2534128A1 (de) 2010-02-08 2012-12-19 Natco Pharma Limited Verfahren zur herstellung von lacosamid
WO2011099033A1 (en) * 2010-02-09 2011-08-18 Msn Laboratories Limited Process for preparing (r)-2-acetamido-n-benzyl-3-methoxy-propionamide
EP2399901A1 (de) 2010-06-23 2011-12-28 Archimica GmbH Zwischenprodukt zur Herstellung von Lacosamid und Verfahren zu dessen Herstellung und Umwandlung zu Lacosamid
EP2621893A1 (de) 2010-10-01 2013-08-07 UCB Pharma GmbH Verfahren zur herstellung von aminosäurederivaten
EP2627639B1 (de) * 2010-10-15 2021-12-22 Nektar Therapeutics N-optional substituierte aryl-2-oligomer-3-alkoxypropionamides
HUE031138T2 (en) 2010-10-19 2017-06-28 Euticals Gmbh A method of producing lacosamide
BR112013013525A2 (pt) 2010-12-02 2016-10-18 Ucb Pharma Gmbh formulação de liberação controlada sólida de lacosamida para administração oral, composição farmacêutica sólida, e, método para a prevenção, alívio e/ou tratamento de uma doença do sistema nervoso central
EP2468261A1 (de) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulierung von Lacosamid
CN104771356A (zh) * 2014-01-09 2015-07-15 山东方明药业集团股份有限公司 一种拉科酰胺注射液及其制备方法
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3678469D1 (de) * 1985-02-15 1991-05-08 Res Corp Technologies Inc Aminosaeure-derivate und ihre anwendung zur herstellung eines antikrampfmittels.
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant

Also Published As

Publication number Publication date
EP1038522B1 (de) 2004-06-02
DE69729392T2 (de) 2005-06-02
EP1038522A3 (de) 2003-01-15
DK0888289T3 (da) 2001-09-03
EP0888289A1 (de) 1999-01-07
CA2248317A1 (en) 1997-09-18
DE69705210T2 (de) 2001-09-20
FR09C0006I1 (de) 2009-04-17
DE122009000010I1 (de) 2009-05-20
DE122009000010I2 (de) 2010-10-21
EP1038522A2 (de) 2000-09-27
ES2218024T3 (es) 2004-11-16
WO1997033861A1 (en) 1997-09-18
JP2000505476A (ja) 2000-05-09
PT888289E (pt) 2001-09-28
ES2157567T3 (es) 2001-08-16
PT1038522E (pt) 2004-10-29
EP0888289B1 (de) 2001-06-13
FR09C0006I2 (fr) 2009-12-18
ATE268169T1 (de) 2004-06-15
DK1038522T3 (da) 2004-10-11
AU718577B2 (en) 2000-04-13
JP3145414B2 (ja) 2001-03-12
CA2248317C (en) 2003-12-02
NL300376I1 (nl) 2009-05-06
DE69705210D1 (de) 2001-07-19
DE69729392D1 (de) 2004-07-08
AU2539497A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
NL300376I1 (nl) Enantiomere anticonvulsieaminozuurderivaten
DK0616807T3 (da) Benzimidazol anvendelig i behandlingen af forstyrrelser i centralnervesystemet
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
BR9808281A (pt) Compostos, composições farmacêuticas, processo para tratar doenças proliferativas e/ou distúrbios do sistema imune e para preparar um composto, e, uso de um composto
EA199900620A1 (ru) Фталазиноны
PT82032B (pt) Processo para a preparacao de derivados de aminoacidos com accao anticonvulsiva e de composicoes farmaceuticas que os contem
ATE399545T1 (de) Mittel zur verringerung der eigeweidefette
EA199800189A1 (ru) Оптически активное производное фенилпиримидина в качестве анальгетика
ATE264104T1 (de) Immunmodulierende arzneimittelzusammenstellung
DK526087A (da) Antikonvulsive aminosyrederivater
DK498889D0 (da) Substituerede aromatiske forbindelser med virkning paa centralnervesystemet
EP0978277A4 (de) Antirheumatische mittel
EP0555479A4 (de)
ATE214384T1 (de) Anticonvulsive aminosäure-derivate
DE69014261D1 (de) N-Azabicyclo[3.3.0]octanamide von aromatischen Säuren.
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
PT88242A (pt) Processo para a preparacao de eteres e tioeteres tendo actividade terapeutica
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств